Xiao Shi S - OmicsDI

Show results for

Unknown (1030)
Proteomics (35)
Transcriptomics (23)
Genomics (9)
Metabolomics (8)
Clinical (1)

Organisms

Homo sapiens (32)
Andropogon gerardi (13)
Bacteria (13)
Canis lupus familiaris (13)
Clostridium perfringens (13)
Cnidaria (13)
Cricetulus griseus (13)
Eukaryota (13)
Fasciola (13)
Hepatitis B virus (13)
Human betaherpesvirus 5 (13)
Madurella mycetomatis (13)
Mesocricetus auratus (13)
Miscanthus x giganteus (13)
Mus musculus (13)
Mycobacterium tuberculosis (13)
Orthoflavivirus (13)
Panicum virgatum (13)
Mus musculus (9)
Saccharomyces cerevisiae (2)
Pteropus alecto (1)
Brassica oleracea (1)
Macaca mulatta (1)
Oryza sativa (1)
Solanum lycopersicum (1)
Oryza sativa Japonica Group (1)
Gallus gallus (1)
Rattus norvegicus (1)
Drosophila melanogaster (1)
Arabidopsis thaliana (1)

Repository

biostudies-arrayexpress (27)
iProX (21)
pride (13)
MetaboLights (8)
EGA (5)
MassIVE (1)

Tissue

Cell culture (4)
Lung (3)
Brain (2)
Epithelial cell (2)
Blood serum (1)
Hepatocyte (1)

Disease

Colorectal cancer (1)
Non-small cell lung carcinoma (1)
Prion disease (1)

Technology Type

Mass Spectrometry (13)
Shotgun proteomics (9)
Mass spectrometry (7)
Illumina OncoArray (1)
NMR spectroscopy (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)
Data-independent acquisition (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Q Exactive (1)
Liquid Chromatography MS - alternating – hilic (1)
Liquid Chromatography MS - Negative (LC-MS (Neg)) (1)
Liquid Chromatography MS - Positive (LC-MS (Pos)) (1)
Nuclear Magnetic Resonance (NMR) - (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2023 (10)
2014 (8)
2022 (7)
2015 (6)
2013 (4)
2010 (3)
2025 (3)
2024 (3)
2020 (3)
2019 (3)
2021 (3)
2016 (2)
2012 (2)
2026 (2)
2011 (1)
2007 (1)
2006 (1)
2017 (1)

CHEBI ID

CHEBI:28834 (4)
CHEBI:16704 (4)
CHEBI:9907 (3)
CHEBI:16708 (3)
CHEBI:17748 (3)
CHEBI:39567 (3)
CHEBI:55328 (3)
CHEBI:72663 (3)
CHEBI:16359 (3)
CHEBI:17568 (3)
CHEBI:17154 (3)
CHEBI:16335 (3)
CHEBI:15756 (3)
CHEBI:17368 (3)
CHEBI:30769 (3)
CHEBI:88864 (2)
CHEBI:36707 (2)
CHEBI:48429 (2)
CHEBI:15702 (2)
CHEBI:28104 (2)
CHEBI:35465 (2)
CHEBI:83053 (2)
CHEBI:16974 (2)
CHEBI:21563 (2)
CHEBI:59270 (2)
CHEBI:28697 (2)
CHEBI:17521 (2)
CHEBI:82984 (2)
CHEBI:32389 (2)
CHEBI:27781 (2)

Metabolite Name

Deoxycholic acid (3)
Uridine (3)
Hypoxanthine (3)
21-Deoxycortisol (2)
Chenodeoxycholic acid (2)
Butylparaben (2)
Uracil (2)
Ursodeoxycholic acid (2)
Carnosine (2)
9,10-DHOME (2)
Taurine (2)
Citric acid (2)
Adenosine (2)
Terephthalic acid (2)
Riboflavin (2)
Palmitic acid (2)
Isoleucine (2)
Adenine (2)
Thymidine (2)
Creatinine (2)
Creatine (2)
Inosine (2)
Asparatate (1)
1-({(1s,4s,6s)-6-isopropyl-3-methyl-4-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-2-cyclohexen-1-yl}methyl)-3-(3-methoxyphenyl)urea (1)
N-({(2r,4s,5r)-5-[3-(3,4-dimethoxyphenyl)-1-methyl-1h-pyrazol-5-yl]-1-azabicyclo[2.2.2]oct-2-yl}methyl)-2-ethylbutanamide (1)
6-o-[(2e)-3-(4-hydroxyphenyl)-2-propenoyl]-1-o-[(2e)-3-phenyl-2-propenoyl]-beta-d-glucopyranose (1)
4-methoxybenzaldehyde n-[6-(tert-butyl)thieno[3,2-d]pyrimidin-4-yl]hydrazone (1)
4-(4-chlorophenyl)-n-(2-pyridinylmethyl)cyclohexanecarboxamide (1)
4h-1-benzopyran-4-one, 6-beta-d-glucopyranosyl-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (s)- (Hemiphloin) (1)
(3r,4s)-4,6,8-trihydroxy-7-methoxy-3-methyl-3,4-dihydro-1h-isochromen-1-one (1)

Study status

Not yet recruiting (1)

Study type

Transcription profiling by array (11)
RNA-seq of coding RNA (7)
ChIP-seq (4)
Other (2)
ChIP-chip by tiling array (1)
Transcription profiling by RT-PCR (1)
Comparative genomic hybridization by array (1)
Interventional (1)

Release Date

2025 (167)
2024 (134)
2022 (127)
2023 (125)
2021 (107)
2020 (102)
2019 (53)
2018 (49)
2017 (47)
2015 (26)
2014 (24)
2016 (23)
2026 (21)
2013 (13)
2012 (13)
2011 (9)
2010 (7)
2007 (3)
2006 (2)
2008 (2)
2009 (1)
2005 (1)
2004 (1)

Lab affiliation

Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030 (2)
college of pharmacy, Nankai university,Tianjin, 300353, China (2)
Cancer Research UK Manchester Institute Transcriptional Networks in Lung Cancer Group (1)
Center for Proteomics and Department of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, OH (1)
Degenerative Diseases Program, Center for Genetic Disorders and Aging Research, Sanford Burnham Prebys Medical Discovery Institute (1)
Department of Pediatrics, The Sixth Affiliated Hospital of Sun Yat-sen University (1)
Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China. (1)
Ludwig-Maximilians-Universität München Protein Analysis Unit Molecular Biology Department Großhadernerstr. 9 82152 Planegg-Martinsried (1)
Professor of Anatomy & Cell Biology (in Physiology and Cellular Biophysics) Columbia University Irving Medical Center (1)
State Key Laboratory for Infectious Disease Prevention and Control, Prion disease department, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China (1)
TongJi Hospital, Huazhong University of Science and Technology (1)

Location

China (1)

Previous page
1 / 111
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 111
Next page

Sort by:

Relevance

Page size

Clinical study of Chai-shi-xiao-pi-tang in treating postoperative cancer-related fatigue of colorectal cancer

Interventions: TCM Group:Chai-shi-xiao-pi-tang;Control Group:NONE Primary outcome(s): PFS-P Study Design: Randomized parallel controlled trial

2676107 | ecrin-mdr-crc

Transcriptome and Gut Microbiota Profiling Analysis of ANIT-Induced Cholestasis and the Effects of Da-Huang-Xiao-Shi Decoction Intervention.

Not available

S-EPMC9769994 | biostudies-literature

Human prion disease iTRAQ

Human prion diseases are fatal neurodegenerative disorders characterized by neuronal damage in brain. Protein S-nitrosylation, the covalent adduction of a NO to cysteine, plays a role in human brain biology, and brain dysfunction is a prominent feature of pPrion disease, yet the direct brain targets...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2017-03-29 | MSV000080756 | MassIVE

INO80-regulated genes in S-phase after MMS treatment

This is transcription analysis of genes regulated by the INO80 chromatin remodeling complex in S-phase of the cell cycle after MMS treatment. Wildtype and ino80 mutant cells were first synchronized at G1 using alpha-factor, the cells were released in to S-phase in the presence of 0.02% MMS. After 45...

ORGANISM(S): Saccharomyces cerevisiae

2010-06-20 | E-GEOD-18555 | biostudies-arrayexpress

Xiao-Yao-San protects against anti-tuberculosis drug-induced liver injury by regulating Grsf1 in the mitochondrial oxidative stress pathway.

Not available

S-EPMC9475289 | biostudies-literature

Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report.

Not available

S-EPMC9577723 | biostudies-literature

The efficacy and safety of Xiao-Ban-Xia-Tang in the treatment of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis.

Not available

S-EPMC11199399 | biostudies-literature

Human prion disease iTRAQ - Proteomic Analyses for the Global S-Nitrosylated Proteins in the Brain Tissues of Different Human Prion Diseases

ORGANISM(S): Homo sapiens (Human)

2015-10-01 | PXD002813 | Pride

Low chorionic villous succinate accumulation associates with recurrent spontaneous abortion risk

Dysregulated extravillous trophoblast invasion and proliferation are known to increase the risk of recurrent spontaneous abortion (RSA); however, the underlying mechanism remains unclear. Herein, in our retrospective observational case-control study we show that villous samples from RSA patients, co...

2021-10-06 | MTBLS2148 | MetaboLights

Comparative metabolomic analysis of exudates of microcystin-producing and microcystin-free Microcystis aeruginosa strains

Cyanobacterial harmful algal blooms (cHABs) dominated by Microcystis aeruginosa threaten the ecological integrity and beneficial uses of lakes globally. In addition to producing hepatotoxic microcystins (MC), M. aeruginosa exudates (MaE) contain various compounds with demonstrat...

2023-01-16 | MTBLS6603 | MetaboLights

Previous page
1 / 111
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 111
Next page

Sort by:

Relevance

Page size

1106 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study status

Study type

Release Date

Lab affiliation

Location

OmicsDI is part of the ELIXIR infrastructure

Tweets